There are various breakthrough points for RA molecular mechanism research, and, among its autoantibodies, anti-citrullinated protein antibody (ACPA) is an important factor that cannot be ignored in RA disease development (1). This evidence concerns the gene PRTN3 and rheumatoid arthritis.